Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,575,198
-
Share change
-
+2,034,525
-
Total reported value
-
$1,013,382,877
-
Put/Call ratio
-
37%
-
Price per share
-
$19.65
-
Number of holders
-
171
-
Value change
-
+$32,160,944
-
Number of buys
-
74
-
Number of sells
-
83
Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q3 2018
As of 30 Sep 2018,
ACORDA THERAPEUTICS INC - COM (ACOR) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,575,198 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, FMR LLC, BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Invesco Ltd., RENAISSANCE TECHNOLOGIES LLC, Partner Fund Management, L.P., and NORTHERN TRUST CORP.
This page lists
171
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.